Ken Langone, Home Depot co-founder, expressed a highly optimistic outlook for Eli Lilly. He suggested the stock could reach $2,000 per share within three to four years. Langone, a long-term investor, noted Eli Lilly now challenges Home Depot as his largest personal investment holding.
This forecast follows recent company developments. CEO David Ricks announced a new $6.5 billion manufacturing facility in Houston. The facility will produce oral GLP-1 medicines. Ricks also highlighted Lilly has captured 70% of new senior Medicare patients for its GLP-1 drugs since July 1.